---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-054712"
form_type: "8-K"
ticker: null
cik: "0001839998"
company_name: "American Oncology Network, Inc."
filed_at: "2023-05-02T23:59:59+00:00"
generated_at: "2026-06-16T03:48:37.551531+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# DTOC enters up to $700K working capital facility with sponsor

## Summary
- Sponsor committed up to $700K in unsecured promissory note; no interest accrues.
- Principal due on earlier of initial business combination or liquidation of the company.
- Drawdowns allowed in min $10K increments; sponsor waives any claim against the trust account.
- Facility intended to fund DTOC's operating expenses prior to a business combination.

## SEC filing metadata
- accession: 0001104659-23-054712
- form_type: 8-K
- cik: 0001839998
- company_name: American Oncology Network, Inc.
- filed_at: 2023-05-02T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1839998/000110465923054712/0001104659-23-054712-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1839998/000110465923054712/tm2314359d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-054712
- JSON: https://secwatch.observer/filing/0001104659-23-054712.json
- Plain text: https://secwatch.observer/filing/0001104659-23-054712.txt

## Key facts
- Debt Financings
  American Oncology Network, Inc. incurred loan of up to $700,000 with Digital Transformation Sponsor LLC at no interest maturing upon the earlier of (i) the date of the consummation of the Company’s initial business combination and (ii) the date of the liquidation of the Company.
  - Instrument: loan
  - Principal: up to $700,000
  - Counterparty: Digital Transformation Sponsor LLC
  - Rate: no interest
  - Maturity: upon the earlier of (i) the date of the consummation of the Company’s initial business combination and (ii) the date of the liquidation of the Company
  - Event: incurrence
  source text: LLC (the “Sponsor”) entered into a promissory note with Digital Transformation Opportunities Corp. (“DTOC” or the “Company”), providing for an aggregate amount of loans up to $700,000 to fund the Company’s operating expenses (the “Working Capital Facility”). The Working Capital Facility bears no interest and all unpaid principal under the Working Capital
  evidence_url: https://www.sec.gov/Archives/edgar/data/1839998/000110465923054712/0001104659-23-054712-index.htm
- Material Agreements
  American Oncology Network, Inc. entered into Working Capital Facility with Digital Transformation Sponsor LLC valued at up to $700,000 (effective 2023-05-01).
  - Action: entry
  - Agreement: credit facility
  - Counterparty: Digital Transformation Sponsor LLC
  - Value: up to $700,000
  - Effective: 2023-05-01
  source text: On May 1, 2023, Digital Transformation Sponsor LLC (the “Sponsor”) entered into a promissory note with Digital Transformation Opportunities Corp. (“DTOC” or the “Company”), providing for an aggregate amount of loans up to $700,000 to fund the Company’s operating expenses (the “Working Capital Facility”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1839998/000110465923054712/0001104659-23-054712-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.